Product Overview Mircera 100mcg 3ml is a medication manufactured by Roche that contains Methoxy Polyethylene Glycol-Epoetin Beta as its active ingredient. It is used to treat anemia in patients with chronic kidney disease who are on dialysis. This medication works by stimulating the production of red blood cells in the body, helping to increase the hemoglobin levels and improve symptoms of anemia. Key Benefits - Stimulates production of red blood cells - Increases hemoglobin levels - Improves symptoms of anemia - Helps manage anemia in patients with chronic kidney disease How It Works Mircera 100mcg 3ml works by mimicking the action of the natural hormone erythropoietin, which is responsible for stimulating the production of red blood cells in the bone marrow. Methoxy Polyethylene Glycol-Epoetin Beta in the medication helps to increase the number of red blood cells, leading to improved oxygen delivery to tissues and organs. Directions for Use 1. Mircera 100mcg 3ml is usually administered by injection under the skin or into a vein by a healthcare professional. 2. The dosage and frequency of administration will be determined by your doctor based on your individual condition and response to treatment. 3. Follow all instructions provided by your healthcare provider and do not self-administer this medication without proper training. Precautions - Inform your doctor about any allergies or medical conditions you have before using Mircera 100mcg 3ml. - It is important to monitor your blood pressure and hemoglobin levels regularly while taking this medication. - Do not use Mircera 100mcg 3ml if you are pregnant or breastfeeding without consulting your doctor. Storage Instructions - Store Mircera 100mcg 3ml in the refrigerator between 2-8°C (36-46°F). - Do not freeze the medication and protect it from light. - Keep the product out of reach of children and pets. Manufacturer Information Mircera 100mcg 3ml is manufactured by Roche, a leading pharmaceutical company known for producing high-quality medications for various medical conditions. Roche is committed to innovation and research to improve patient outcomes and quality of life.